Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Am J Kidney Dis ; 31(1): 108-15, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9428460

RESUMO

A 71-year-old woman was treated for a relapsing pulmonary tuberculosis with reinstitution of rifampicin after a medication-free interval of 2 years. After ingestion of the second dose, she developed severe hemolytic anemia and acute renal failure (ARF) necessitating dialysis. We demonstrated the presence in the patient's serum of rifampicin-dependent immunoglobulin G (IgG) and IgM antibodies, which caused red blood cell lysis through interaction with the I antigen on the erythrocyte surface. A review of the literature yielded 48 cases of rifampicin-associated renal failure. A subgroup of 37 patients could be distinguished, which, analogous to our case, suddenly developed ARF and frequently also developed hemolytic anemia and/or thrombocytopenia during intermittent or interrupted treatment. Regarding the pathogenesis of the ARF, renal biopsy consistently revealed tubular lesions. Although intravascular hemolysis with hemoglobinuria may play a role, it is not uniformly present. Our demonstration of an antibody with anti-I specificity provides a possible explanation. The I antigen is also expressed on tubular epithelium and may, therefore, be the target structure through which rifampicin-antibody complexes lead to tubular cell destruction. The other cases of rifampicin-associated ARF were unrelated to this subgroup: two cases of rapidly progressive glomerulonephritis, five cases of acute interstitial nephritis, and four cases of light chain proteinuria were recorded.


Assuntos
Injúria Renal Aguda/induzido quimicamente , Antibióticos Antituberculose/efeitos adversos , Rifampina/efeitos adversos , Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/imunologia , Injúria Renal Aguda/fisiopatologia , Idoso , Anemia Hemolítica/induzido quimicamente , Anemia Hemolítica/epidemiologia , Anemia Hemolítica/imunologia , Anemia Hemolítica/fisiopatologia , Antibióticos Antituberculose/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Feminino , Humanos , Rifampina/uso terapêutico , Fatores de Tempo , Tuberculose Pulmonar/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA